Patience David — SEC Form 4 filings
SEC reporting owner CIK 1970009. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-25 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 10,757 shares, $32,247 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 20,997 shares, $17,326 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: purchase of 7,100 shares @ $2.43 ($17,253) in TriSalus Life Sciences, Inc., filed 2026-05-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TriSalus Life Sciences, Inc. (TLSI) | Chief Financial Officer | 6 | 2 legs · 10,757 sh · $32,247 | — | 6 |
| Accelerate Diagnostics, Inc (AXDX) | Chief Financial Officer | 7 | — | 4 legs · 20,997 sh · $17,326 | 12 |
Form 4 filings — Patience David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Tax withholding (F): 14,650 @ $4.46 | EDGAR |
| 2026-05-18 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Purchase (P): 7,100 @ $2.43 | EDGAR |
| 2026-02-23 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Purchase (P): 3,657 @ $4.10 | EDGAR |
| 2025-11-25 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2025-08-29 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 248,899 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 200,000 @ $0 · Grant/award (A): 290,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 20,000 @ $0 · Sale (S): 6,816 @ $0.71 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 1,500 @ $0 · Sale (S): 535 @ $1.09 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 37,468 @ $0 · Sale (S): 13,296 @ $0.87 · Option exercise (M): 37,468 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 37,468 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Accelerate Diagnostics, Inc (AXDX) | Option exercise (M): 1,000 @ $0 · Sale (S): 350 @ $0.96 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Accelerate Diagnostics, Inc (AXDX) | Grant/award (A): 16,666 · Grant/award (A): 16,666 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1970009 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →